Antz Christoph Rudiger

Across 2 filings between 2026, Antz Christoph Rudiger, Chief Executive Officer, Director, has disclosed $7.7K in transactions — all concentrated in Veraxa Biotech AG - Post de-SPAC (VRXA). Their disclosed trades are heavily weighted toward buying — $7.7K in buys and $0 in sells. The largest single open-market purchase on record is $7.7K in Veraxa Biotech AG - Post de-SPAC. Data is sourced from official SEC Form 3, 4, and 5 filings.